METTLER TOLEDO INTERNATIONAL INC/ Q3 FY2024 earnings call

Management Statement and Operational Highlights:

• Laboratory grew ~5% in the third quarter, with strong growth in Process Analytics and new product launches like a stain-free automated cell counter and microplate reader.
• Industrial sales were flat in the third quarter due to market headwinds in China; product inspection grew 1%, and the portfolio was enhanced with new weighing terminals.
• Food Retail sales declined from significant prior-year project activity.
• Geographically, Americas sales declined 1%, Europe sales grew 1%, Asia/Rest of the World results were in line with expectations, and China returned to sales growth but had soft underlying demand.
• Service business, representing ~25% of sales, grew 7% YTD with strong Q3 growth, focusing on expanding the service network and leveraging data analytics.
• Investments in innovation, the Spinnaker go-to-market strategy, and the SternDrive program for efficiency.

Segment Performance:

• Laboratory: Third quarter sales increased 5%; year-to-date, local currency sales grew 2%.
• Industrial: Third quarter sales were flat; year-to-date, local currency sales decreased 2% (core Industrial down 4%, product inspection up 1%).
• Food Retail: Third quarter sales declined 20%; year-to-date, local currency sales decreased 14%.

Guidance:

• Fourth quarter 2024: Expect local currency sales to grow ~8% (including 6% benefit from prior-year shipping delays), adjusted EPS in the range of $11.63 to $11.78.
• Full year 2024: Local currency sales growth forecast unchanged at ~2% (excluding shipping delays), adjusted EPS in the range of $40.35 to $40.50, free cash flow expected to be ~$850 million.
• 2025: Local currency sales expected to increase ~3% (including 1.5% headwind from shipping delays), adjusted EPS forecast in the range of $41.85 to $42.50, free cash flow ~$860 million, share repurchases ~$875 million.

Risks:

• Market conditions remain soft, especially in China.
• Uncertainty in core markets, global economy, and geopolitics.
• Impact of prior-year shipping delays on 2025 sales and margin expansion.
• Variable compensation and currency headwinds affecting EPS.

Q: On fiscal '25 assumptions for Labs vs Industrials and Services growth.

A: Shawn Vadala stated Labs are expected to grow low to mid-single digit on reported basis but mid to high single digit ex shipping delays; core Industrial and Product Inspection are estimated to grow low single digit on both reported and adjusted basis; Services are expected to grow mid to high single digits.

Q: On China growth stimulus and long-term outlook.

A: Patrick Kaltenbach mentioned no stimulus factored in 2025 growth forecast, but long-term high single-digit growth in China is expected.

Q: On margins and Lab portfolio refresh.

A: Shawn Vadala said operating margin for 2025 is flattish to current year, with Lab portfolio refresh helping as part of overall margin drivers but individual product launches not moving the needle drastically